Parexel Names Keri Mattox Chief Business Officer
22. Oktober 2024 08:55 ET
|
Parexel International LLC
DURHAM, N.C., Oct. 22, 2024 (GLOBE NEWSWIRE) -- Parexel, one of the world’s largest clinical research organizations (CROs) providing the full range of Phase I to IV clinical development services,...
Parexel’s Teri Karcher Named to 2024 PharmaVoice 100
08. Oktober 2024 08:55 ET
|
Parexel International LLC
Chief Drug Development Officer and Executive Vice President, Head of Launch Excellence recognized for pioneering leadership in drug development DURHAM, N.C., Oct. 08, 2024 (GLOBE NEWSWIRE) --...
Parexel Earns Prestigious Society for Clinical Research Sites Eagle Award for Second Consecutive Year
30. September 2024 10:00 ET
|
Parexel International LLC
DURHAM, N.C., Sept. 30, 2024 (GLOBE NEWSWIRE) -- Parexel, one of the world’s largest clinical research organizations (CROs) providing the full range of Phase I to IV clinical development services,...
Parexel Strengthens Real World Research Offering
04. September 2024 09:55 ET
|
Parexel International LLC
DURHAM, N.C., Sept. 04, 2024 (GLOBE NEWSWIRE) -- Parexel, one of the world’s largest clinical research organizations (CROs) providing the full range of Phase I to IV clinical development services,...
Parexel’s Near-Term Greenhouse Gas Reduction Targets Validated by Science Based Target Initiative (SBTi)
12. August 2024 08:55 ET
|
Parexel International LLC
DURHAM, N.C., Aug. 12, 2024 (GLOBE NEWSWIRE) -- Parexel, one of the world’s largest clinical research organizations (CROs) providing the full range of Phase I to IV clinical development services,...
Parexel Releases 2023 Environmental, Social and Governance Report
29. Juli 2024 08:55 ET
|
Parexel International LLC
DURHAM, N.C., July 29, 2024 (GLOBE NEWSWIRE) -- Parexel, one of the world’s largest clinical research organizations (CROs) providing the full range of Phase I to IV clinical development services,...
Parexel and Palantir Expand Collaboration to Accelerate Clinical Data Delivery and Power Clinical Outcomes for Patients
25. April 2024 06:59 ET
|
Parexel International LLC
DURHAM, N.C. and DENVER, April 25, 2024 (GLOBE NEWSWIRE) -- Parexel, one of the world’s largest clinical research organizations (CROs) providing the full range of Phase I to IV clinical development...
Parexel Named “Best Contract Research Organization” at 17th Annual Vaccine Industry Excellence (ViE) Awards
04. April 2024 09:00 ET
|
Parexel International LLC
DURHAM, N.C., April 04, 2024 (GLOBE NEWSWIRE) -- Parexel, one of the world’s largest clinical research organizations (CROs) providing the full range of Phase I to IV clinical development services,...
Parexel Announces CEO Succession Plan
18. März 2024 09:05 ET
|
Parexel International LLC
DURHAM, N.C., March 18, 2024 (GLOBE NEWSWIRE) -- Parexel, one of the world’s largest clinical research organizations (CROs) providing the full range of Phase I to IV clinical development services,...
Parexel Appoints Susan R. Salka to Board of Directors
01. Februar 2024 09:00 ET
|
Parexel International LLC
DURHAM, N.C., Feb. 01, 2024 (GLOBE NEWSWIRE) -- Parexel, one of the world’s largest clinical research organizations (CROs) providing the full range of Phase I to IV clinical development services,...